PolyProx Therapeutics is a spin out of the Department of Pharmacology at the University of Cambridge, and is based on over a decade of research and intellectual property from Founder, Professor Laura Itzhaki’s laboratory. Professor Itzhaki is joined at PolyProx Therapeutics by serial Cambridge biotech entrepreneurs Kevin Moulder as Chief Operating Officer and Andrew Sandham as Executive Chairman. PolyProx Therapeutics will develop a new class of drugs, called Polyproxin™ molecules, that are able to selectively target tumour cells and trigger the natural degradation machinery contained within the cell to arrest tumour growth.
Total raised: $5.71M
Investors 2
| Date | Name | Website |
| - | Parkwalk A... | parkwalkad... |
| - | Cambridge ... | cic.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 02.03.2020 | Seed | $1.28M | - |
| 30.04.2019 | Seed | $4.43M | - |
Mentions in press and media 8
| Date | Title | Description | Source |
| 02.03.2020 | PolyProx Therapeutics raises an additional £1m seed financin... | PolyProx Therapeutics raises an additional £1m seed financing to validate polyproxin® drug leads in ... | cambridgen... |
| 02.03.2020 | PolyProx Therapeutics raises an additional £1m seed financin... | PolyProx Therapeutics, a biotechnology company focused on the discovery and development of novel bio... | cambridgen... |
| 02.03.2020 | PolyProx Therapeutics Raises Additional £1M in Seed Financin... | PolyProx Therapeutics, a Cambridge, England, UK-based biotechnology company focused on the discovery... | finsmes.co... |
| 02.03.2020 | PolyProx raises an additional £1 million seed financing from... | PolyProx Therapeutics raises an additional £1 million seed financing from new investor, LifeArc, to ... | cic.vc/new... |
| 30.04.2019 | PolyProx Therapeutics raises £3.4m seed financing to validat... | PolyProx Therapeutics, a new biotechnology company focused on the discovery and development of novel... | cambridgen... |
| 30.04.2019 | PolyProx Therapeutics Raises £3.4m in Seed Financing | PolyProx Therapeutics, a Cambridge, UK-based biotechnology company focused on the discovery and deve... | finsmes.co... |
| 30.04.2019 | CIC co-leads £3.4 million seed financing for PolyProx Therap... | Funding will support research operations to validate a novel class of drugs to treat cancer Cambrid... | cic.vc/new... |
| 30.04.2019 | PolyProx Therapeutics raises £3.4m seed financing to validat... | PolyProx Therapeutics raises £3.4m seed financing to validate novel class of cancer drugs 30-04-201... | cambridgen... |